Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Siegert, C.E.H.
Right arrow Articles by de Bruin, T.W.A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Siegert, C.E.H.
Right arrow Articles by de Bruin, T.W.A.

(Stroke. 1995;26:496-497.)
© 1995 American Heart Association, Inc.


Articles

Superior Sagittal Sinus Thrombosis and Thyrotoxicosis

Possible Association in Two Cases

C.E.H. Siegert, MD, PhD; A.H.M. Smelt, MD, PhD T.W.A. de Bruin, MD, PhD

From the Departments of Internal Medicine, University Hospital Leiden and University Hospital Utrecht (T.W.A. de B.) (Netherlands).

Background Superior sagittal sinus thrombosis is an uncommon cerebrovascular accident that is frequently associated with diseases that may contribute to the development of thrombosis through hypercoagulability, stasis of the local blood stream, and abnormalities of the vessel wall. In approximately 25% of cases underlying diseases remain unrecognized.

Case Descriptions Two patients with superior sagittal sinus thrombosis during a thyrotoxic phase of Graves' disease are described. Both patients presented with hemiplegia, seizures, and a large goiter.

Conclusions The development of superior sagittal sinus thrombosis is multifactorial. Patients with thyrotoxicosis and a large goiter may be predisposed to the development of superior sagittal sinus thrombosis through hypercoagulability and stasis of the local venous blood flow.


Key Words: Graves' disease • sinus thrombosis • thrombosis




This article has been cited by other articles:


Home page
StrokeHome page
E. S. Roach, M. R. Golomb, R. Adams, J. Biller, S. Daniels, G. deVeber, D. Ferriero, B. V. Jones, F. J. Kirkham, R. M. Scott, et al.
Management of Stroke in Infants and Children: A Scientific Statement From a Special Writing Group of the American Heart Association Stroke Council and the Council on Cardiovascular Disease in the Young
Stroke, September 1, 2008; 39(9): 2644 - 2691.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
A. Squizzato, V.E.A. Gerdes, D.P.M. Brandjes, H.R. Buller, and J. Stam
Thyroid Diseases and Cerebrovascular Disease
Stroke, October 1, 2005; 36(10): 2302 - 2310.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. K. Horne III, K. K. Singh, K. G. Rosenfeld, R. Wesley, M. C. Skarulis, P. K. Merryman, A. Cullinane, R. Costello, A. Patterson, T. Eggerman, et al.
Is Thyroid Hormone Suppression Therapy Prothrombotic?
J. Clin. Endocrinol. Metab., September 1, 2004; 89(9): 4469 - 4473.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
D. A. Dulli, C. C. Luzzio, E. C. Williams, and H. S. Schutta
Cerebral Venous Thrombosis and Activated Protein C Resistance
Stroke, October 1, 1996; 27(10): 1731 - 1733.
[Abstract] [Full Text]